Intimate partner violence and stress-related disorders: from epigenomics to resilience.

Journal: Frontiers in global women's health
Published Date:

Abstract

Intimate Partner Violence (IPV) is a major public health problem to be addressed with innovative and interconnecting strategies for ensuring the psychophysical health of the surviving woman. According to the World Health Organization, 27% of women worldwide have experienced physical and sexual IPV in their lifetime. Most of the studies on gender-based violence focus on short-term effects, while long-term effects are often marginally included even though they represent the most serious and complex consequences. The molecular mechanisms underlying stress-related disorders in IPV victims are multiple and include dysregulation of the hypothalamic-pituitary-adrenal axis, inflammatory response, epigenetic modifications, neurotransmitter imbalances, structural changes in the brain, and oxidative stress. This review aims to explore the long-term health consequences of intimate partner violence (IPV), emphasizing the biological and psychological mechanisms underlying stress-related disorders and resilience. By integrating findings from epigenetics, microbiome research, and artificial intelligence (AI)-based data analysis, we highlight novel strategies for mitigating IPV-related trauma and improving recovery pathways. Genome-wide environment interaction studies, enhanced by AI-assisted data analysis, offer a promising public health approach for identifying factors that contribute to stress-related disorders and those that promote resilience, thus guiding more effective prevention and intervention strategies.

Authors

  • Anna Carannante
    Department of Environment and Health, Italian Institute of Health, Rome, Italy.
  • Marco Giustini
    Reparto Epidemiologia ambientale e sociale Dipartimento Ambiente e Salute (DAMSA) Istituto Superiore di Sanità, Viale Regina Elena, 299, Roma, 00161, Italy.
  • Federica Rota
    EPIGET-Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Paolo Bailo
    Section of Legal Medicine, School of Law, University of Camerino, Piazza Cavour, 19, 62032 Camerino, Italy.
  • Andrea Piccinini
    Department of Biomedical Sciences for Health, Università Degli Studi di Milano, Milan, Italy.
  • Gabriella Izzo
    Press Office, Italian Institute of Health, Rome, Italy.
  • Valentina Bollati
    EPIGET-Epidemiology, Epigenetics and Toxicology Lab, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Simona Gaudi
    Department of Environment and Health, Italian Institute of Health, Rome, Italy.

Keywords

No keywords available for this article.